3-(Phenylmethyl) 3-azabicyclo[3.1.0]hexane-2,3-dicarboxylate | 172404-35-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-(Phenylmethyl) 3-azabicyclo[3.1.0]hexane-2,3-dicarboxylate
• 英文别名: 3-phenylmethoxycarbonyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid
• CAS: 172404-35-2
• 化学式: C₁₄H₁₅NO₄
• 分子量: 261.27
• InChiKey: AXUGRJLGJPMWQJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  66.8
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
  申请人：——

  公开号：US20030216325A1

  公开（公告）日：2003-11-20

  The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

  本发明公开了具有HCV蛋白酶抑制活性的新化合物，以及制备这种化合物的方法。在另一实施例中，本发明公开了包含这种化合物的药物组合物，以及使用它们治疗与HCV蛋白酶相关的疾病的方法。
• Non-covalent inhibitors of urokinase and blood vessel formation
  申请人：Corvas International, Inc.

  公开号：US20020037857A1

  公开（公告）日：2002-03-28

  Novel compounds having activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have Pi a group having an amidino or guanidino moiety or derivative thereof. These compounds are useful in vitro for monitoring plasminogen activator levels and in vivo in treatment of conditions which are ameliorated by inhibition of or decreased activity of urokinase and in treating pathologic conditions wherein blood vessel formation is related to a pathologic condition.

  提供了一种具有作为尿激酶非共价抑制剂活性并在减少或抑制血管形成方面具有活性的新化合物。这些化合物具有Pi基团，其中含有一个酰胺基团或鸟胺基团或其衍生物。这些化合物在体外用于监测纤溶酶原激活剂水平，在体内用于治疗通过抑制尿激酶或降低其活性而得到改善的病症，以及用于治疗血管形成与病理病变相关的病理状况。
• PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS
  申请人：Schering Corporation

  公开号：EP1385870B1

  公开（公告）日：2010-03-17
• NITRILE DERIVATIVES AS CATHEPSIN K INHIBITORS
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP1244621B1

  公开（公告）日：2006-09-13
• NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS
  申请人：SCHERING CORPORATION

  公开号：EP1481000A2

  公开（公告）日：2004-12-01